EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   4.2.2.3 | Bacterial Infections |
21340021 |
Genetically engineered alginate lyase-PEG conjugates exhibit enhanced catalytic function and reduced immunoreactivity. |
therapeutic application
unassigned |
3
0 |
| 4.2.2.3 | Bacterial Infections |
27576102 |
Hyaluronan-cholesterol nanohydrogels: Characterisation and effectiveness in carrying alginate lyase. |
diagnostic usage
therapeutic application
unassigned |
1
2
0 |
| 4.2.2.3 | Communicable Diseases |
11948558 |
Preparation and properties of alginate lyase modified with poly(ethylene glycol). |
unassigned |
0 |
| 4.2.2.3 | Cystic Fibrosis |
8319887 |
Sequence of a gene encoding a (poly ManA) alginate lyase active on Pseudomonas aeruginosa alginate. |
unassigned |
0 |
| 4.2.2.3 | Cystic Fibrosis |
16519750 |
Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms. |
causal interaction
therapeutic application
unassigned |
2
2
0 |
| 4.2.2.3 | Cystic Fibrosis |
21340021 |
Genetically engineered alginate lyase-PEG conjugates exhibit enhanced catalytic function and reduced immunoreactivity. |
therapeutic application
unassigned |
3
0 |
| 4.2.2.3 | Cystic Fibrosis |
23966229 |
Alginate lyase and ciprofloxacin co-immobilization on biopolymeric microspheres for cystic fibrosis treatment. |
therapeutic application
unassigned |
1
0 |
| 4.2.2.3 | Cystic Fibrosis |
25027418 |
Impact of alginate-producing Pseudomonas aeruginosa on alveolar macrophage apoptotic cell clearance. |
causal interaction
unassigned |
3
0 |
| 4.2.2.3 | Cystic Fibrosis |
27061817 |
The effect of alginate lyase on the gentamicin resistance of Pseudomonas aeruginosa in mucoid biofilms. |
unassigned |
0 |
| 4.2.2.3 | Cystic Fibrosis |
27253324 |
Modeling and Re-Engineering of Azotobacter vinelandii Alginate Lyase to Enhance Its Catalytic Efficiency for Accelerating Biofilm Degradation. |
therapeutic application
unassigned |
4
0 |
